Fig. 2From: Which severe COVID-19 patients could benefit from high dose dexamethasone? A Bayesian post-hoc reanalysis of the COVIDICUS randomized clinical trialLooking for treatment by subset interactions in terms of hazard ratio (HR) of 60-day mortality. CRP C reactive protein, MV invasive mechanical ventilation, SAPS Simplified Acute Physiology ScoreBack to article page